MobiHealth News July 11, 2019
Laura Lovett

CEO Sean Duffy discusses clinical validation, digital therapeutics and the new opportunity for a digital provider.

Omada Health, the digital health company that recently raised $73 million, came on to the digital health scene in 2011 with a focus on diabetes and chronic conditions. As the company continues to carve out its legacy in the digital health world, it is taking a cue from a more established industry.

“We’re one of the most life sciences-like digital health companies. We don’t fit perfectly into any box,” CEO of Omada Sean Duffy told MobiHealthNews.

Duffy said that he’s always seen Omada’s product as a therapeutic—not a solely a piece of software. Initially this was met with confusion from potential partner organizations...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Investments, Provider, Technology, Trends
Embracing digital transformation with a digital factory
Why Should Payers Spend Money on Digital Diabetes Solutions?
How Remote Patient Monitoring and AI Personalize Care
Digital Platforms Streamline Medication Access and Delivery
Too much data? Wearables for senior care have value but providers must know how to parse their output, experts say

Share This Article